Beneficial Effects of Combined Treatment With Rosiglitazone and Exercise on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Author(s) -
Nikolaos P.E. Kadoglou,
Fotios Iliadis,
Christos D. Liapis,
Despina Perrea,
Nikoleta Angelopoulou,
Miltiadis Alevizos
Publication year - 2007
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc07-0341
Subject(s) - medicine , rosiglitazone , type 2 diabetes , diabetes mellitus , risk factor , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom